DeepWork Portfolio Careers

CorMatrix

cormatrix.com

CorMatrix® Cardiovascular, Inc. develops and delivers innovative biomaterial devices that harness the body’s innate ability to repair damaged cardiac and vascular tissues. CorMatrix® enables surgeons to restore the native anatomy of these tissues in need of repair, serving as a superior alternative to synthetic or cross-linked materials. CorMatrix® is currently researching, developing, and commercializing a platform technology known as Extracellular Matrix (ECM®) for a variety of cardiovascular and other indications. The company has U.S. clearance and European CE mark for its device technology. Since its launch in 2006, CorMatrix has been used at more than 1,000 hospitals across the U.S. and implanted in over 145,000 cardiac procedures.